Baduanjin Intervention in Clinical Studies After Coronary Revascularization Surgery

Starting soon · Not applicable

Conditions studied: Percutaneous Coronary Intervention, Myocardial Revascularization, Coronary Artery Disease

In brief

1. To evaluate the efficacy and safety of the Baduanjin exercise programme in patients following coronary revascularisation surgery; 2. To develop a traditional Chinese medicine (TCM) rehabilitation protocol and evaluation system for patients following coronary revascularisation surgery; 3. To clarify the advantages of TCM rehabilitation in the post-operative management of coronary revascularisation surgery and to provide high-level evidence-based medical evidence for TCM rehabilitation protocols.

Key facts

Study ID

NCT07607951

Run by

Liu Qiang

People needed

310

Starts

2026-07-01

Expected to finish

2028-12-31

Last updated by the study team

2026-05-27

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants who meet the diagnostic criteria for coronary heart disease
• Participants who underwent successful percutaneous coronary intervention
• Participants aged between 18 and 80
• Participants of any gender
• Participants who have signed an informed consent form

You may not qualify if…

• Subjects with severe hepatic or renal impairment
• subjects with severe electrolyte disturbances
• subjects with severe haematological disorders or malignant tumours
• pregnant or breastfeeding women
• subjects with psychiatric disorders
• subjects with cognitive impairment (e.g. dementia, post-stroke cognitive impairment) that prevents them from understanding or carrying out exercise instructions
• Subjects scheduled to undergo repeat revascularisation surgery in the near future
• Subjects with other severe cardiovascular diseases such as uncontrolled hypertension, angina pectoris, rapid arrhythmias, high-degree or complete atrioventricular block (without a pacemaker), acute severe aortic stenosis, decompensated heart failure (NYHA Class IV), deep vein thrombosis, obstructive hypertrophic cardiomyopathy, acute pericarditis or myocarditis, acute endocarditis, or acute aortic dissection
• Participants with acute pulmonary embolism or chronic lung disease accompanied by symptoms of dyspnoea (occurring at rest or with minimal exertion)
• Subjects with impaired limb mobility or who are unable to move independently;
• Subjects with Shy-Drager syndrome
• Subjects who have participated in a clinical trial involving other drugs or exercise interventions within the past month
• Subjects deemed by the investigator to have other conditions rendering them unsuitable for participation in the trial

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.